clinical trial · NCT00650195
Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg
HealthyMetolazone Tablets 10 mgZaroloxyn® Tablets 10 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan metolazone 10 mg tablets to Celltech Zaroxolyn® 10 mg tablets following a single, oral 10 mg (1 x 10 mg) dose administration under fasting conditions.
started
Feb 1, 2004
primary completion
Feb 1, 2004
completion
Mar 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Metolazone Tablets (10 mg; Mylan) and Zaroloxyn® Tablets (10 mg; Celltech) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol